AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
01 Nov 2011 04:00 PM
RNS
Total Voting Rights
01 Nov 2011 07:00 AM
RNS
Transaction in Own Shares
31 Oct 2011 07:00 AM
RNS
Transaction in Own Shares
28 Oct 2011 03:00 PM
RNS
Director/PDMR Shareholding
28 Oct 2011 07:00 AM
RNS
Transaction in Own Shares
27 Oct 2011 07:05 AM
RNS
FDA extends dapa action date by three months
27 Oct 2011 07:00 AM
RNS
3rd Quarter Results - Part 2 of 2
27 Oct 2011 07:00 AM
RNS
3rd Quarter Results - Part 1 of 2
27 Oct 2011 07:00 AM
RNS
Transaction in Own Shares
26 Oct 2011 09:00 AM
RNS
Notice of Results
26 Oct 2011 07:00 AM
RNS
Transaction in Own Shares
25 Oct 2011 07:00 AM
RNS
Transaction in Own Shares
24 Oct 2011 07:00 AM
RNS
Transaction in Own Shares
21 Oct 2011 07:00 AM
RNS
Transaction in Own Shares
20 Oct 2011 07:00 AM
RNS
Transaction in Own Shares
19 Oct 2011 07:00 AM
RNS
Transaction in Own Shares
18 Oct 2011 07:00 AM
RNS
Transaction in Own Shares
17 Oct 2011 07:00 AM
RNS
Transaction in Own Shares
14 Oct 2011 07:00 AM
RNS
Transaction in Own Shares
13 Oct 2011 07:00 AM
RNS
Transaction in Own Shares
12 Oct 2011 07:00 AM
RNS
Transaction in Own Shares
11 Oct 2011 07:00 AM
RNS
Transaction in Own Shares
10 Oct 2011 07:00 AM
RNS
Transaction in Own Shares
07 Oct 2011 07:00 AM
RNS
Transaction in Own Shares
06 Oct 2011 07:00 AM
RNS
Transaction in Own Shares
05 Oct 2011 01:30 PM
RNS
Settles with Accord and Intas over Seroquel XR
05 Oct 2011 07:00 AM
RNS
Transaction in Own Shares
04 Oct 2011 07:00 AM
RNS
Transaction in Own Shares
03 Oct 2011 03:00 PM
RNS
Total Voting Rights
03 Oct 2011 07:00 AM
RNS
Transaction in Own Shares
30 Sep 2011 02:00 PM
RNS
Share Repurchase Programme
30 Sep 2011 07:00 AM
RNS
US Seroquel XR Patent Litigation
30 Sep 2011 07:00 AM
RNS
Transaction in Own Shares
29 Sep 2011 07:00 AM
RNS
Transaction in Own Shares
28 Sep 2011 07:00 AM
RNS
Transaction in Own Shares
27 Sep 2011 07:00 AM
RNS
Transaction in Own Shares
26 Sep 2011 07:00 AM
RNS
Transaction in Own Shares
23 Sep 2011 01:22 PM
RNS
Komboglyze receives positive CHMP opinion
23 Sep 2011 07:00 AM
RNS
Transaction in Own Shares
22 Sep 2011 07:00 AM
RNS
Transaction in Own Shares
21 Sep 2011 07:00 AM
RNS
Transaction in Own Shares
20 Sep 2011 07:00 AM
RNS
Transaction in Own Shares
19 Sep 2011 07:00 AM
RNS
Transaction in Own Shares
16 Sep 2011 07:00 AM
RNS
Transaction in Own Shares
15 Sep 2011 07:00 AM
RNS
Transaction in Own Shares
14 Sep 2011 07:00 AM
RNS
Transaction in Own Shares
13 Sep 2011 08:30 AM
RNS
Block Listing Application
13 Sep 2011 08:30 AM
RNS
Blocklisting Interim Review
13 Sep 2011 07:00 AM
RNS
Transaction in Own Shares
12 Sep 2011 07:00 AM
RNS
Transaction in Own Shares

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100

Latest directors dealings